Jeffrey Anthony Duchemin und Harvard Bioscience - Info zur Person

(1 - 29 von 39

)

2015: CEO Alumnus Jeffrey Duchemin ’89 to address Class of at...

www.umassd.edu

UMass Dartmouth will welcome alumnus and President, CEO, and Director of Harvard Bioscience Inc., Jeffrey Duchemin '89 as this year's ...

Harvard Bioscience Hires Jeffrey Duchemin As CEO | |...

www.finanzen.ch

(RTTNews) - Harvard Bioscience, Inc. (HBIO) said Tuesday that it has hired veteran life science executive Jeffrey Duchemin as its new Chief ...

Harvard Bioscience Elects James Green as Chairman of Board of...

www.teletrader.com

Jeffrey Duchemin, President and CEO, said, “James Green has been a valuable member of the Board since he joined two years ago. He brings ...

Harvard Bioscience Elects New Board Chairman - Medical Product...

www.mpo-mag.com

Company replacing former chair, who had served for the past four years.

Jeffrey Duchemin Net Worth (2022) | wallmine

de.wallmine.com

Jeffrey Duchemin HBIO stock SEC Form 4 insider trading. Jeffrey has made over 10 trades of the Harvard Bioscience stock since 2015, according to the Form

Harvard Bioscience, Inc. (HBIO) CEO Jeffrey Duchemin on Q1 ...seekingalpha.com › article ›

seekingalpha.com

Company Participants. Corey Manchester – Vice President and Corporate Controller. Jeffrey Duchemin – President and Chief Executive Officer.

Harvard Bioscience Elects James Green as Chairman of ...www.advfn.com › news_Harvard-...

www.advfn.com

Jeffrey Duchemin, President and CEO, said, “James Green has been a valuable member of the Board since he joined two years ago. He brings ...

Harvard Bioscience, Inc. (HBIO) - Seeking Alpha

seekingalpha.com

Leading the call today will be Jeffrey Duchemin, President and Chief Executive Officer; and Kam Unninayar, Chief Financial Officer of Harvard ...

Harvard Bioscience Subsidiary Data Sciences International Launches...

www.advfn.com

HBIO Harvard Bioscience Inc Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research

Edited Transcript of HBIO earnings conference call or presentation

finance.yahoo.com

the Harvard Bioscience Fourth Quarter Earnings Conference Call. Leading the call today will be Jeffrey Duchemin, President and Chief Executive Officer; and Robert Gagnon, Chief Financial Officer of Harvard Bioscience ...

citybizlist : Citybizlist : Harvard Bioscience's (HBIO) CEO Jeffrey...

citybizlist.com

Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q Results - Earnings Call Transcript By Seeking Alpha. Harvard Bioscience, Inc.

Harvard Bioscience To Showcase Products at Experimental ...finance.yahoo.com › news › harva...

finance.yahoo.com

... and customers through product demonstrations and sponsored events,” said Jeffrey Duchemin, President and CEO of Harvard Bioscience.

Harvard Bioscience Inc. Announces Jeffrey A. Duchemin as New CEO |...

www.biospace.com

Harvard Bioscience Inc. Announces Jeffrey A. Duchemin as New CEO - read this article along with other careers information, tips and advice on BioSpace

The Daily Biotech Pulse: Roche Presents Positive Hemlibra ...

finance.yahoo.com

... (NASDAQ: GNFT); Harvard Bioscience, Inc. (NASDAQ: HBIO)(announced departure of CEO Jeffrey Duchemin); Heat Biologics Inc (NASDAQ: ...

HARVARD BIOSCIENCE INC - Edgar Onlinecontent.edgar-online.com › ExternalLink › EDGAR

content.edgar-online.com

3. Mr. Jeffrey Anthony Duchemin ,. born on October 19, 1965,. with the business address 84 October Hill Road, Hollistion,. Massachusetts , USA ...

Jeffrey Duchemin Archives - Stock Spinoffs

www.stockspinoffs.com

Harvard Bioscience (HBIO) recently completed the spinoff of its regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technologies ...

Data Sciences International launches inhalation exposure system |...

www.medicaldesignandoutsourcing.com

Data Sciences International, a subsidiary of Harvard Bioscience, recently launched a new inhalation and exposure system.

Xconomy: East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, &...

xconomy.com

—Holliston, MA-based Harvard Bioscience (NASDAQ: HBIO) named Jeffrey Duchemin its new CEO, replacing interim chief David Green.

HARVARD BIOSCIENCE INC (Form: 8-K, Received: :11:39)

content.edgar-online.com

HARVARD BIOSCIENCE, INC. By: /s/ Earl Lewis. Name: Earl Lewis. Title: Chairman. EXECUTIVE. /s/ Jeffrey Duchemin. Jeffrey A. Duchemin ...

HBIO Announces Details of Approved Spin-Off of Harvard Apparatus...

ir.biostage.com

The Harvard Bioscience, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid= CONTACT: Jeffrey Duchemin

HBIO Archives - Stock Spinoffs

www.stockspinoffs.com

HART HART Spinoff Harvard Apparatus Regenerative Technologies Harvard Bioscience HBIO HBIO Management Stock Options Jeffrey Duchemin Jeffrey ...

Harvard Bioscience Insider Buying and Selling (NASDAQ:HBIO)

www.marketbeat.com

, Jeffrey Duchemin, CEO, Sell, 6,332, $4.50, $28James W. Green, Director, Buy, 2,500, $5.74, $14Robert E.

Harvard Bioscience Inc

www.lawinsider.com

This Separation and Release Agreement (the “Release Agreement”) is entered into by Jeffrey Duchemin (the “Executive”) and Harvard Bioscience, Inc. (the ...